NEKTAR THERAPEUTICS Quarterly Return On Assets in % from Q3 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nektar Therapeutics quarterly/annual Return On Assets history and growth rate from Q3 2011 to Q3 2024.
  • Nektar Therapeutics Return On Assets for the quarter ending September 30, 2024 was -46.6 %, a 12.4% increase year-over-year.
  • Nektar Therapeutics annual Return On Assets for 2023 was -58.2 %, a 33.6% decline from 2022.
  • Nektar Therapeutics annual Return On Assets for 2022 was -43.6 %, a 8.67% decline from 2021.
  • Nektar Therapeutics annual Return On Assets for 2021 was -40.1 %, a 47.4% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -46.6 +6.6 +12.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -44.8 +3.34 +6.93% Apr 1, 2024 Jun 30, 2024
Q1 2024 -40.6 +16.3 +28.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.2 -14.6 -33.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -53.2 -5.18 -10.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48.2 +0.86 +1.75% Apr 1, 2023 Jun 30, 2023
Q1 2023 -56.9 -15.9 -38.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -43.6 -3.48 -8.67% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48 -12.9 -36.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49 -16.8 -51.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -41 -12.9 -45.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.1 -12.9 -47.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -35.1 -9.89 -39.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.3 -9.53 -41.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.1 -5.29 -23.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -27.2 -6.07 -28.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -25.2 -5.15 -25.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -22.8 -3.17 -16.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -22.8 -52.5 -177% Jan 1, 2020 Mar 31, 2020
Q4 2019 -21.2 -59 -156% Oct 1, 2019 Dec 31, 2019
Q3 2019 -20.1 -73.6 -137% Jul 1, 2019 Sep 30, 2019
Q2 2019 -19.6 -112 -121% Apr 1, 2019 Jun 30, 2019
Q1 2019 29.6 +54.6 Jan 1, 2019 Mar 31, 2019
Q4 2018 37.8 +56.3 Oct 1, 2018 Dec 31, 2018
Q3 2018 53.6 +73.1 Jul 1, 2018 Sep 30, 2018
Q2 2018 92.6 +134 Apr 1, 2018 Jun 30, 2018
Q1 2018 -24.9 +14.9 +37.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -18.5 +13.1 +41.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -19.5 +15.7 +44.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -41.9 -14.5 -52.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -39.9 -11.5 -40.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -31.5 -14.5 -84.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -35.2 -19.5 -124% Jul 1, 2016 Sep 30, 2016
Q2 2016 -27.4 -28.7 -2212% Apr 1, 2016 Jun 30, 2016
Q1 2016 -28.4 -33.9 -615% Jan 1, 2016 Mar 31, 2016
Q4 2015 -17.1 -5.61 -49% Oct 1, 2015 Dec 31, 2015
Q3 2015 -15.8 -3.84 -32.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 1.3 +33.4 Apr 1, 2015 Jun 30, 2015
Q1 2015 5.51 +41.2 Jan 1, 2015 Mar 31, 2015
Q4 2014 -11.5 +27.2 +70.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -11.9 +26.5 +69% Jul 1, 2014 Sep 30, 2014
Q2 2014 -32.1 +8.81 +21.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -35.7 -1.19 -3.45% Jan 1, 2014 Mar 31, 2014
Q4 2013 -38.6 -10 -34.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -38.4 -13.5 -54.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -40.9 -20 -95.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 -34.5 -13.3 -62.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -28.6 -8.24 -40.4% Oct 1, 2012 Dec 31, 2012
Q3 2012 -24.9 -6.2 -33.1% Jul 1, 2012 Sep 30, 2012
Q2 2012 -20.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -21.2 Jan 1, 2012 Mar 31, 2012
Q4 2011 -20.4 Oct 1, 2011 Dec 31, 2011
Q3 2011 -18.7 Jul 1, 2011 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.